Ablative Therapy for Esophageal Dysplasia and Early Malignancy: Focus on RFA
Ablative therapies have been utilized with increasing frequency for the treatment of Barrett’s esophagus with and without dysplasia. Multiple modalities are available for topical ablation of the esophagus, but radiofrequency ablation (RFA) remains the most commonly used. There have been significant...
Main Authors: | Rebecca Tuttle, Steven J. Nurkin, Steven N. Hochwald |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2014/642063 |
Similar Items
-
Ablative Therapies for Colorectal Polyps and Malignancy
by: Jacqueline Oxenberg, et al.
Published: (2014-01-01) -
Evolving Ablative Therapies for Hepatic Malignancy
by: Smit Singla, et al.
Published: (2014-01-01) -
Wide-field radiofrequency ablation (RFA) of anal high-grade dysplasia (HSIL) decreases recurrence over targeted ablation
by: Stephen E. Goldstone, M, et al.
Published: (2018-06-01) -
Efficacy of percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma in elderly patients
by: Perna G, et al.
Published: (2011-08-01) -
Short-term survival after radiofrequency Ablation (RFA) of the lung in swine model
by: Salem, Mir
Published: (2009)